Aclaris therapeutics to participate in the svb leerink virtual 11th annual global healthcare conference

Wayne, pa., feb. 02, 2022 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that dr. neal walker, president and ceo of aclaris, will participate in a fireside chat at the svb leerink virtual 11th annual global healthcare conference on wednesday, february 16, 2022 at 9:20 a.m. et. management will be available february 16th throughout the day for virtual 1x1 meetings.
ACRS Ratings Summary
ACRS Quant Ranking